SEC 13F Intelligence

Zenyatta Capital Management LP / BSX

Zenyatta Capital Management LP’s Boston Scientific Corp Position

Does Zenyatta Capital Management LP own Boston Scientific Corp (BSX)? Not currently — the last reported position was 50.0K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$3M
Q4 2023
Shares
50.0K
% of Portfolio
+1.12%
Quarters Held
4
position exited

Position History BSX

Reported value by quarter
Q4 ’22: $5MQ4 ’22Q1 ’23: $2MQ1 ’23Q3 ’23: $7MQ3 ’23Q4 ’23: $3MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202350.0K$3M+1.12%
Q3 2023140.0K$7M+4.01%
Q1 202340.0K$2M+2.15%
Q4 2022110.0K$5M+2.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Zenyatta Capital Management LP’s full portfolio or all institutional holders of BSX.